XML 79 R13.htm IDEA: XBRL DOCUMENT v3.19.3
Consolidated Statements of Equity - USD ($)
$ in Millions
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Accumulated Other Comprehensive Loss
Unearned ESOP Shares [Member]
Noncontrolling Interests
The Dow Chemical Company [Domain]
The Dow Chemical Company [Domain]
Common Stock [Member]
The Dow Chemical Company [Domain]
Additional Paid-in Capital [Member]
The Dow Chemical Company [Domain]
Retained Earnings [Member]
The Dow Chemical Company [Domain]
Accumulated Other Comprehensive Loss
The Dow Chemical Company [Domain]
Unearned ESOP Shares [Member]
The Dow Chemical Company [Domain]
Noncontrolling Interests
ESOP shares acquired           $ 0             $ 0  
Total Equity, Beginning at Dec. 31, 2017   $ 0 $ 6,553 $ 33,742 $ (8,591) (189)     $ 0 $ 6,553 $ 33,742 $ (8,591) (189)  
Stock Issued                   0        
Stock-based compensation and allocation of ESOP shares     294     50       294     50  
Adjustments to Additional Paid in Capital, Other                   0        
Stock Issued During Period, Value, Parent Company Stock - DWDP     106             106        
Net income available for The Dow Chemical Company common stockholder       3,750             3,750      
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees       (3,158)             3,158      
Transfer of Business Under Common Control $ (276)     204 0   $ 0 $ 276     204 0    
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification       989 (1,037)           989 (1,037)    
Other     0 13             (13)      
Other comprehensive income 482       482     482       482    
Total Equity, Ending at Sep. 30, 2018 33,955 0 6,953 35,106 (9,146) (139)   33,955   6,953 35,106 (9,146) (139) $ 1,181
ESOP shares acquired           0             0  
Total Equity, Beginning at Jun. 30, 2018   0 6,861 35,192 (9,387) (145)     0 6,861 35,192 (9,387) (145)  
Stock Issued                   0        
Stock-based compensation and allocation of ESOP shares     71     6       71     6  
Adjustments to Additional Paid in Capital, Other                   0        
Stock Issued During Period, Value, Parent Company Stock - DWDP     21             21        
Net income available for The Dow Chemical Company common stockholder       1,013             1,013      
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees       (1,048)             1,048      
Transfer of Business Under Common Control       52 0   0       52 0    
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification       0 0           0 0    
Other     0 (1)             1      
Other comprehensive income 241       241     241       241    
Total Equity, Ending at Sep. 30, 2018 33,955 0 6,953 35,106 (9,146) (139)   33,955   6,953 35,106 (9,146) (139) 1,181
The Dow Chemical Company’s stockholders’ equity 32,774             32,774            
The Dow Chemical Company’s stockholders’ equity 32,483             32,483            
ESOP shares acquired           (2)             (2)  
Total Equity, Beginning at Dec. 31, 2018 33,621 0 7,042 35,460 (9,885) (134)   33,621 0 7,042 35,460 (9,885) (134)  
Stock Issued                   11        
Stock-based compensation and allocation of ESOP shares     202     41       202     41  
Adjustments to Additional Paid in Capital, Other                   (38)        
Stock Issued During Period, Value, Parent Company Stock - DWDP     28             28        
Net income available for The Dow Chemical Company common stockholder       964             1,068      
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees       (535)             535      
Transfer of Business Under Common Control 1,935     14,861 793   353 61     16,022 793    
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification       (111) 0           (111) 0    
Other     37 11             (11)      
Other comprehensive income (127)       (127)     (127)       (127)    
Total Equity, Ending at Sep. 30, 2019 17,986 7 7,239 19,873 (9,219) (95)   18,367   7,245 19,849 (9,219) (95) 587
ESOP shares acquired           (2)             (2)  
Total Equity, Beginning at Jun. 30, 2019   7 7,186 20,110 (8,988) (99)     $ 0 7,192 19,575 (8,988) (99)  
Stock Issued                   5        
Stock-based compensation and allocation of ESOP shares     55     6       55     6  
Adjustments to Additional Paid in Capital, Other                   (7)        
Stock Issued During Period, Value, Parent Company Stock - DWDP     0             0        
Net income available for The Dow Chemical Company common stockholder       333             310      
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees       0             0      
Transfer of Business Under Common Control       50 0   $ 0       32 0    
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification       0 0           0 0    
Other     7 4             (4)      
Other comprehensive income (231)       (231)     (231)       (231)    
Total Equity, Ending at Sep. 30, 2019 17,986 $ 7 $ 7,239 $ 19,873 $ (9,219) $ (95)   18,367   $ 7,245 $ 19,849 $ (9,219) $ (95) $ 587
The Dow Chemical Company’s stockholders’ equity $ 17,399             $ 17,780